Lv3
265 积分 2021-07-21 加入
Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 trial
11天前
已完结
Neoadjuvant chemotherapy plus camrelizumab for locally advanced cervical cancer (NACI study): a multicentre, single-arm, phase 2 trial
11天前
已完结
Meta-Analysis of Clinical Trial on the Comparative Efficacy and Safety Profiles of Immunotherapeutic Strategies in Cervical Cancer
11天前
已完结
Immunotherapeutics in Clinical Trials for Cervical Cancer
11天前
已完结
The prognostic value of routinely performed minor salivary gland assessments in primary Sjögren's syndrome
15天前
已完结
10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension
17天前
已完结
The clinical and economic burden of non-adherence with oral bisphosphonates in osteoporotic patients
17天前
已完结
Rheumatoid arthritis is a risk factor for refracture in patients with fragility fractures
18天前
已完结
Age-Related Changes in Cortical Bone Content of Insulin-Like Growth Factor Binding Protein (IGFBP)-3, IGFBP-5, Osteoprotegerin, and Calcium in Postmenopausal Osteoporosis: A Cross-Sectional Study
18天前
已完结
Hip Fracture in Men-Survival and Subsequent Fractures: A Cohort Study with 22-Year Follow-Up
19天前
已完结
皖公网安备34019202002308
